Arthur Y Elliott - Net Worth and Insider Trading

Arthur Y Elliott Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Arthur Y Elliott owns 1 companies in total, including iBio Inc (IBIO) .

Click here to see the complete history of Arthur Y Elliott’s form 4 insider trades.

Insider Ownership Summary of Arthur Y Elliott

Ticker Comapny Transaction Date Type of Owner
IBIO iBio Inc 2010-10-29 director

Arthur Y Elliott Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Arthur Y Elliott Ownership Network

Ownership Network List of Arthur Y Elliott

No Data

Ownership Network Relation of Arthur Y Elliott

Insider Network Chart

Arthur Y Elliott Owned Company Details

What does iBio Inc do?

Who are the key executives at iBio Inc?

Arthur Y Elliott is the director of iBio Inc. Other key executives at iBio Inc include Chief Scientific Officer Martin Brenner , Interim CFO Felipe Duran , and director & CEO and Executive Chairman Isett Thomas Francis 3rd .

iBio Inc (IBIO) Insider Trades Summary

Over the past 18 months, Arthur Y Elliott made no insider transaction in iBio Inc (IBIO). Other recent insider transactions involving iBio Inc (IBIO) include a net sale of 84,655 shares made by Martin Brenner ,

In summary, during the past 3 months, insiders sold 0 shares of iBio Inc (IBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,233 shares of iBio Inc (IBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,233 shares.

iBio Inc (IBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

iBio Inc Insider Transactions

No Available Data

Arthur Y Elliott Mailing Address

Above is the net worth, insider trading, and ownership report for Arthur Y Elliott. You might contact Arthur Y Elliott via mailing address: 9 Innovation Way, Suite 100, Newark De 19711.

Discussions on Arthur Y Elliott

No discussions yet.